UPDATED LONG-TERM SURVIVAL AND SAFETY FROM A MULTI-CENTER, OPEN-LABEL, PIVOTAL PHASE 2 STUDY OF AZEDRA (R) IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC PHEOCHROMOCYTOMA OR PARAGANGLIOMA

Jimenez, C; Chin, BB; Noto, RB; Dillon, JS; Solnes, L; DiPippo, VA; Stambler, N; Wong, V; Pryma, DA

JOURNAL OF UROLOGY, 2020; 203 (): E632